Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …

Sarcopenia, a condition of low muscle mass, quality, and strength, is commonly found in
patients with chronic liver disease (CLD) and is associated with adverse clinical outcomes …

Background & Aims Nonalcoholic fatty liver disease (NAFLD) and sarcopenia can be
associated with advanced liver disease. Our aim was to assess the association between …

Liver transplantation (LT) is currently the only curative treatment option for selected patients
with end stage liver disease or hepatocellular carcinoma. Improving waiting list-mortality …

A glucagon-like peptide-1 receptor agonist (GLP-1RA) has recently been established as a
pharmacological option for the treatment of type 2 diabetes. Recent studies have …

Background Skeletal muscle generates force and movements and maintains posture. Under
pathological conditions, muscle fibers suffer an imbalance in protein synthesis/degradation …

Background: Hepatic sarcopenia is one of many complications associated with chronic liver
disease (CLD) and has a high mortality rate; however, the liver-muscle axis is not fully …

Background: Sarcopenia seems to be an emerging health issue worldwide, concerning the
progressive loss of skeletal muscle mass, accompanied by adverse outcomes. Asthma is a …

Objective The use of psoas muscle index (PMI) in acute-on-chronic liver failure (ACLF) has
not been reported, and the aim of this study was to evaluate the predictive value of PMI for …

In recent years, the terms sarcopenia, sarcopenic obesity, and osteosarcopenic obesity
(OSO) were coined to define a situation in elderly people strongly associated with frailty and …